Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Xaracoll® (bupivacaine) – New drug approval
August 31, 2020 - Innocoll announced the FDA approval of Xaracoll (bupivacaine), in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.
